HU171946B - Process for producing 11-alpha, 15-alpha-tetrahydropyranyloxy-omega-aryl-prostaglandine derivatives - Google Patents

Process for producing 11-alpha, 15-alpha-tetrahydropyranyloxy-omega-aryl-prostaglandine derivatives

Info

Publication number
HU171946B
HU171946B HU73PI00000481A HUPI000481A HU171946B HU 171946 B HU171946 B HU 171946B HU 73PI00000481 A HU73PI00000481 A HU 73PI00000481A HU PI000481 A HUPI000481 A HU PI000481A HU 171946 B HU171946 B HU 171946B
Authority
HU
Hungary
Prior art keywords
alpha
tetrahydropyranyloxy
omega
aryl
producing
Prior art date
Application number
HU73PI00000481A
Other languages
Hungarian (hu)
Inventor
Michael R Johnson
Hans-Juergen E Hess
Thomas K Schaaf
Jasjit S Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU171946B publication Critical patent/HU171946B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
HU73PI00000481A 1972-07-13 1973-07-12 Process for producing 11-alpha, 15-alpha-tetrahydropyranyloxy-omega-aryl-prostaglandine derivatives HU171946B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (1)

Publication Number Publication Date
HU171946B true HU171946B (en) 1978-04-28

Family

ID=23034697

Family Applications (4)

Application Number Title Priority Date Filing Date
HU73PI00000481A HU171946B (en) 1972-07-13 1973-07-12 Process for producing 11-alpha, 15-alpha-tetrahydropyranyloxy-omega-aryl-prostaglandine derivatives
HU73PI00000480A HU171158B (en) 1972-07-13 1973-07-12 Process for producing 2-oxo-omega-aralkyl-phosphonic acid dialkyl esters
HU73PI00000387A HU171156B (en) 1972-07-13 1973-07-12 Process for preparing omega-aryl-nor-prostaglandins
HU73PI00000482A HU172058B (en) 1972-07-13 1973-07-12 Process for producing 3-alpha, 5-alpha-dihydroxy-2-beta-bracket-aryl-alkenyl-bracket closed-cyclipenthyl-acetic acid gamma-lactone derivatives

Family Applications After (3)

Application Number Title Priority Date Filing Date
HU73PI00000480A HU171158B (en) 1972-07-13 1973-07-12 Process for producing 2-oxo-omega-aralkyl-phosphonic acid dialkyl esters
HU73PI00000387A HU171156B (en) 1972-07-13 1973-07-12 Process for preparing omega-aryl-nor-prostaglandins
HU73PI00000482A HU172058B (en) 1972-07-13 1973-07-12 Process for producing 3-alpha, 5-alpha-dihydroxy-2-beta-bracket-aryl-alkenyl-bracket closed-cyclipenthyl-acetic acid gamma-lactone derivatives

Country Status (25)

Country Link
JP (4) JPS5241257B2 (en)
AR (2) AR209064A1 (en)
AT (1) AT367033B (en)
BE (1) BE802231A (en)
CA (1) CA1041495A (en)
CH (1) CH593254A5 (en)
CS (1) CS201027B2 (en)
DD (2) DD109210A5 (en)
DE (1) DE2334945A1 (en)
ES (4) ES416865A1 (en)
FI (1) FI57583C (en)
FR (1) FR2192834B1 (en)
GB (1) GB1446341A (en)
HU (4) HU171946B (en)
IE (1) IE37909B1 (en)
IL (2) IL42691A (en)
IN (1) IN138789B (en)
LU (1) LU68015A1 (en)
NL (1) NL7309792A (en)
NO (2) NO143741C (en)
PH (1) PH11461A (en)
SE (3) SE7705946L (en)
SU (4) SU644384A3 (en)
YU (1) YU187773A (en)
ZA (1) ZA734769B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2463432C2 (en) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
DE2416193C2 (en) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin analogs, processes for their preparation and their use as cytoprotective agents
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
SE9002596D0 (en) * 1990-08-08 1990-08-08 Pharmacia Ab A METHOD OF SYNTHESIS OF PROSTAGLANDIN DERIVATIVES
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100578616B1 (en) * 2004-07-23 2006-05-10 한미약품 주식회사 Method for the preparation of d-erythro-2,2-difluoro-2-deoxy-1-oxoribose
UA121108C2 (en) * 2013-12-13 2020-04-10 Аллерган, Інк. Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
IL50311A (en) * 1972-06-02 1977-08-31 Pfizer Dimethyl alkoxy-2-oxoalkyl phosphonates and their preparattion

Also Published As

Publication number Publication date
SE7705945L (en) 1977-05-20
ATA620773A (en) 1981-10-15
ES437037A1 (en) 1977-01-01
IN138789B (en) 1976-04-03
FR2192834A1 (en) 1974-02-15
AT367033B (en) 1982-05-25
SE7705947L (en) 1977-05-20
IE37909B1 (en) 1977-11-09
SE7705946L (en) 1977-05-20
JPS52122349A (en) 1977-10-14
JPS4992053A (en) 1974-09-03
AR214383A1 (en) 1979-06-15
CS201027B2 (en) 1980-10-31
SU584791A3 (en) 1977-12-15
BE802231A (en) 1974-01-14
CH593254A5 (en) 1977-11-30
SU645564A3 (en) 1979-01-30
ZA734769B (en) 1974-06-26
HU172058B (en) 1978-05-28
ES416865A1 (en) 1976-03-01
JPS5293753A (en) 1977-08-06
ES437039A1 (en) 1977-01-01
AR209064A1 (en) 1977-03-31
PH11461A (en) 1978-02-01
IL50308A0 (en) 1976-10-31
NO144830C (en) 1981-11-18
JPS5241257B2 (en) 1977-10-17
NO143741B (en) 1980-12-29
CA1041495A (en) 1978-10-31
FR2192834B1 (en) 1979-04-06
GB1446341A (en) 1976-08-18
HU171158B (en) 1977-11-28
SU645563A3 (en) 1979-01-30
DE2334945A1 (en) 1974-03-07
ES437038A1 (en) 1977-01-01
IE37909L (en) 1974-01-13
FI57583C (en) 1980-09-10
DD109210A5 (en) 1974-10-20
HU171156B (en) 1977-11-28
YU187773A (en) 1982-02-25
LU68015A1 (en) 1974-01-21
NO143741C (en) 1981-04-08
IL42691A (en) 1979-07-25
NO743492L (en) 1974-01-15
NL7309792A (en) 1974-01-15
DD116459A5 (en) 1975-11-20
IL42691A0 (en) 1973-10-25
JPS5297958A (en) 1977-08-17
FI57583B (en) 1980-05-30
NO144830B (en) 1981-08-10
AU5778473A (en) 1975-01-09
SU644384A3 (en) 1979-01-25

Similar Documents

Publication Publication Date Title
CS183689B2 (en) Process for preparing pyridylphenoxyalkane derivatives
YU41187B (en) Process for preparing new 3,4-dihydrocarbostyrye derivatives
HU172703B (en) Process for producing 16-phenoxy-omega-tetranor-prostaglandine derivatives
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
YU39297B (en) Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones
YU34892B (en) Process for preparing novel benzoyl-benzofuran derivatives
HU173215B (en) Process for producing insuline, insuline-analogues and insuline derivatives
HU171946B (en) Process for producing 11-alpha, 15-alpha-tetrahydropyranyloxy-omega-aryl-prostaglandine derivatives
HU172069B (en) Process for producing 1-bracket-3-disubstituted-phosphono-thioureido-bracket closed-2-bracket-3-substituted-ureidoor -thioureido-bracket closed-benzene derivatives
CH610900A5 (en) Process for preparing novelaminopyrazoloisoquinoline derivatives
HU171818B (en) Process for preparing omega-aryl- and oxa-prostaglandin-p-diphenyl-ester derivatives
HU167876B (en) Process for producing 9-10-secoestrane derivatives
HU173381B (en) Process for producing carboxy-cyclopropane derivatives
YU35588B (en) Process for preparing novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
CA1034115A (en) Process for producing desacetoxycephalosporin derivatives
CS184873B1 (en) Method for producing 1,8-naphtyridine derivatives
CA967976A (en) Process for producing trimethyl-p-benzoquinone
YU229979A (en) Process for obtaining novel 1,4-benzodixane derivatives
HU171199B (en) Process for producing 2-amino-4-hydroxy-7,8-dihydro-pteridines
CH613977A5 (en) Process for preparing tricyclohexyl-tin derivatives
YU36701B (en) Process for obtaining as-triazinoz5,6-ccquinoline derivatives
ZA735014B (en) Process for producing new nitrofurane derivatives
IL43170A0 (en) Process for producing 7-acylamido-7-alkoxycephalosporins
YU35253B (en) Process for preparing 2-imidazolidione derivatives
CA1033749A (en) Process for producing 9,10-seco-oestrane derivatives